Implementierungsleitfaden Therapieziele Onkologie - Local Development build (v1.0.0-ballot) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

• Narrative Content
• XML
• JSON

: Geplante Systemtherapie – Pembrolizumab + Chemotherapie (KEYNOTE-522, Beispiel)

Raw json | Download

{
  "resourceType" : "MedicationRequest",
  "id" : "MedicationRequestPembroChemoNeoadjuvantMamma",
  "meta" : {
    "profile" : [
      🔗 "https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/onko-tumorboard-medication-request"
    ]
  },
  "language" : "en",
  "text" : {
    "status" : "extensions",
    "div" : "<div xml:lang=\"en\" lang=\"en\"><hr/><p><b>English</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: MedicationRequest MedicationRequestPembroChemoNeoadjuvantMamma</b></p><a name=\"en-MedicationRequestPembroChemoNeoadjuvantMamma\"> </a><a name=\"en-hcMedicationRequestPembroChemoNeoadjuvantMamma\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-onko-tumorboard-medication-request.html\">Tumorboard MedicationRequest</a></p></div><p><b>EnLiST-Änderungstyp (Extension)</b>: <span title=\"Codes:{https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/enlist-change-type new}\">New LoT</span></p><p><b>status</b>: Completed</p><p><b>intent</b>: Plan</p><p><b>category</b>: <span title=\"Codes:{http://loinc.org 85232-7}\">Tumor board Consult note</span></p><p><b>medication</b>: <span title=\"Codes:\">Pembrolizumab + Carboplatin/Paclitaxel, gefolgt von Pembrolizumab + Epirubicin/Cyclophosphamid (KEYNOTE-522)</span></p><p><b>subject</b>: <a href=\"Patient-PatientinMamma.html\">Sabine Baumann  Female, DoB: 1977-06-24</a></p></div>"
  },
  "extension" : [
    {
      "url" : "https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/enlist-change",
      "valueCodeableConcept" : {
        "coding" : [
          {
            "system" : "https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/enlist-change-type",
            "code" : "new",
            "display" : "New LoT"
          }
        ]
      }
    }
  ],
  "status" : "completed",
  "intent" : "plan",
  "category" : [
    {
      "coding" : [
        {
          "system" : "http://loinc.org",
          "code" : "85232-7",
          "display" : "Tumor board Consult note"
        }
      ]
    }
  ],
  "medicationCodeableConcept" : {
    "text" : "Pembrolizumab + Carboplatin/Paclitaxel, gefolgt von Pembrolizumab + Epirubicin/Cyclophosphamid (KEYNOTE-522)"
  },
  "subject" : {
    🔗 "reference" : "Patient/PatientinMamma"
  }
}